News & Updates

Couples infected with SARS-CoV-2 while receiving assisted reproductive technology (ART) treatment had lower quality embryo and blastocyst rates compared with uninfected couples in a  multicentre cohort study.

Children whose mothers experienced violence during pregnancy are at higher risk of developing overweight from birth to middle childhood, suggests a recent study, underscoring intergenerational transmission of social adversity in children's health.

Accelerometry appears to be an accurate measure of quality of life (QoL) in patients with malignant pleural effusion (MPE), as shown in a study. It is also a useful tool for examining subtle differences in patients following various treatment regimens, particularly drainage protocols in MPE.

The monoclonal antibody dupilumab, alone or in combination with conventional agents, appeared to effectively control bullous pemphigoid (BP), a study from China has shown.

New drug applications approved by US FDA as of 16-31 July 2023 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.